Development of a core set of performance measures for evaluating schizophrenia treatment services

Psychiatric Services

Volumn 63, Issue 6, 2012, Pages 584-591

  Addington, Donald Emile ^a   Mckenzie, Emily ^a   Wang, JianLi ^a,b   Smith, Harvey P ^a   Adams, Beverly ^a   Ismail, Zahinoor ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; MEASUREMENT; MENTAL HEALTH SERVICE; QUESTIONNAIRE; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

ALBERTA; DELPHI TECHNIQUE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; QUESTIONNAIRES; SCHIZOPHRENIA;

EID: 84861880188     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201100453     Document Type: Article

References (67)

1. Hearnshaw HM, Harker RM, Cheater FM, et al: Expert consensus on the desirable characteristics of review criteria for improvement of health care quality. Quality Health Care 10:173-178, 2001
2. McGlynn EA, Asch SM, Adams J, et al: The quality of health care delivered to adults in the United States. New England Journal of Medicine 348:2635-2645, 2003 (Pubitemid 36741592)
3. Druss BG, Miller CL, Rosenheck RA, et al: Mental health care quality under managed care in the United States: a view from the Health Employer Data and Information Set (HEDIS). American Journal of Psychiatry 159:860-862, 2002 (Pubitemid 34465064)
4. Institute of Medicine, Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Improving the Quality of Health Care for Mental and Substance-Use Conditions. Washington DC, National Academies Press, 2007
5. Wobrock T, Weinmann S, Falkai P, et al: Quality assurance in psychiatry: quality indicators and guideline implementation. European Archives of Psychiatry and Clinical Neuroscience 259(suppl 2):S219-S226, 2009
6. Andrews G, Sanderson K, Corry J, et al: Cost-effectiveness of current and optimal treatment for schizophrenia. British Journal of Psychiatry 183:427-435, 2003 (Pubitemid 37357575)
7. Buchanan RW, Kreyenbuhl J, Zito JM, et al: The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcome. Schizophrenia Bulletin 28:63-73, 2002 (Pubitemid 34534750)
8. Hermann RC, Finnerty M, Provost S, et al: Process measures for the assessment and improvement of quality of care for schizophrenia. Schizophrenia Bulletin 28:95-104, 2002 (Pubitemid 34534753)
9. Health Indicators. Ottawa, Canadian Institute of Health Information, 2011
10. Roadmap Initiative Launching the Process: The Final Year. Ottawa, Canadian Institute for Health Information, 2003
11. Measures TP: Performance-Based Planning Manual (Preliminary Draft). Agter NCHRP project 8-32(2). Washington, DC, Federal Highway Administration Operations Unit, 2002
12. Norquist G: Role of outcome measurement in psychiatry; in Outcome Measurement in Psychiatry: A Critical Review. Edited by IsHak WW, Burt T, Sederer LI. Washington DC, American Psychiatric Press, 2002
13. Dixon LB, Lehman AF, Levine J: Conventional antipsychotic medications for schizophrenia. Schizophrenia Bulletin 21:567-577, 1995
14. Dixon LB, Lehman AF: Family Interventions for schizophrenia. Schizophrenia Bulletin 21:631-643, 1995
15. Tarrier N, Yusupoff L, Kinney C, et al: Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. British Medical Journal 17:303-307, 1998 (Pubitemid 28353823)
16. National Service Framework for Mental Health: Modern Standard and Service Models. London, United Kingdom, Department of Health, 1999
17. Behavioral Healthcare Performance Measurement System. Alexandria, Va, National Association of State Mental Health Program Directors Research Institute, 2011
18. Health System Performance Research Network: Hospital Report: Mental Health. Toronto, Ontario, Government of Ontario, Ontario Hospital Association, and the Hospital Report Research Collaborative, 2007
19. McEwan K, Goldner EM: Accountability and Performance Indicators for Mental Health Services and Supports: A Resource Kit. Ottawa, Government Services Canada, 2000
20. Canadian Psychiatric Association Working Group: Clinical practice guidelines: treatment of schizophrenia. Canadian Journal of Psychiatry 50(suppl 1):1S-56S, 2005
21. American Psychiatric Association: Practice guideline for the treatment of patients with schizophrenia, 2nd ed. American Journal of Psychiatry 161(suppl 2):1-55, 2004
22. Canadian Task Force on Preventive Health Care: New grades for recommendations from the Canadian Task Force on Preventive Health Care. Canadian Medical Association Journal 169:207-208, 2003
23. Fitch K, Bernstein SJ, Aguilar MS, et al: The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, Calif, RAND, 2001
24. Jones J, Hunter D: Consensus methods for medical and health services research. British Medical Journal 311:376-380, 1995
25. Black N, Murphy MK, Lamping D, et al: Consensus development methods: a review of best practice in creating clinical guidelines. Journal of Health Services and Research Policy 4:236-248, 1999 (Pubitemid 29473735)
26. Hasson F, Keeney S, McKenna H: Research guidelines for the Delphi survey technique. Journal of Advanced Nursing 32:1008-1015, 2000
27. Hermann RC, Palmer H, Leff S, et al: Achieving consensus across diverse stakeholders on quality measures for mental healthcare. Medical Care 42:1246-1253, 2004 (Pubitemid 39627302)
28. Fiander M, Burns T: Essential components of schizophrenia care: a Delphi approach. Acta Psychiatrica Scandinavia 98:400-405, 1998 (Pubitemid 28529685)
29. Shield T, Campbell SM, Rogers A, et al: Quality indicators for primary care mental health services. Quality and Safety in Health Care 12:100-106, 2003 (Pubitemid 36458146)
30. Fiander M, Burns T: A Delphi approach to describing service models of community mental health practice. Psychiatric Services 51:656-658, 2000 (Pubitemid 30256643)
31. Burns T, Fiander M, Audini B: A Delphi approach to characterising "relapse" as used in UK clinical practice. International Journal of Social Psychiatry 46:220-230, 2000
32. Addington D, Mckenzie E, Addington J, et al: Performance measures for early psychosis treatment services. Psychiatric Services 56:1570-1582, 2005 (Pubitemid 41790118)
33. Cleary PD, Edgman-Levitan S: Health care quality: incorporating consumer perspectives. JAMA 278:1608-1612, 1997 (Pubitemid 27490732)
34. Donabedian A: The quality of care: how can it be assessed? JAMA 260:1743-1748, 1988
35. Burnam A: Selecting performance measures by consensus: an appropriate extension of the Delphi method? Psychiatric Services 56: 1583, 2005
36. Polit D, Hungler B: Essentials of Nursing Research. New York, Lippincott, 1997
37. Murphy MK, Black NA, Lamping DL, et al: Consensus Development Methods and Their Use in Clinical Guideline Development. London, National Health Services, Research and Development, Health Technology Assessment Programme, 1998
38. Campbell SM, Cantrill JA: Consensus methods in prescribing research. Journal of Clinical Pharmacy and Therapeutics 26:5-14, 2001 (Pubitemid 32250806)
39. Statistical Package for Social Sciences, version 11.01. Chicago, SPSS, 2003
40. Adair CE, Simpson L, Birdsell JM, et al: Performance Measurement Systems in Health and Mental Health Services: Models, Practices and Effectiveness - A State of the Science Review. Alberta, Canada, Alberta Heritage Foundation for Medical Research, 2003
41. National Information Priorities and Strategies Under the Second National Mental Health Plan. Canberra, Australia, Australian Health Ministers' Advisory Council, National Mental Health Working Group, 2003
42. Carlwood P, Mason A, Goldacre M: Health Outcome Indicators: Severe Mental Illness. Oxford, United Kingdom, National Centre for Outcomes Development, 1999
43. Arns P, Rogers ES, Cook J, et al: The IAPSRS toolkit: development, utility, and relation to other performance measurement systems. Psychiatric Rehabilitation Journal 25:43-52, 2001 (Pubitemid 34149857)
44. Report of the American Psychiatric Association Task Force on Quality Indicators. Washington, DC, American Psychiatric Association, 1999
45. Kessler RC, Berglund PA, Bruce ML, et al: The prevalence and correlates of untreated serious mental illness. Health Services Research 36:987-1007, 2001 (Pubitemid 34016594)
46. Popkin MK, Lurie N, Manning W, et al: Changes in the process of care for Medicaid patients with schizophrenia in Utah's Prepaid Mental Health Plan. Psychiatric Services 49: 518-523, 1998 (Pubitemid 28175691)
47. Dixon L: Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 35(suppl): S93-100, 1999
48. Young AS, Sullivan G, Burnam MA, et al: Measuring the quality of outpatient treatment for schizophrenia. Archives of General Psychiatry 55:611-617, 1998 (Pubitemid 28340348)
49. Ashton C, Del Junco D, Soucheck J, et al: The association between the quality of inpatient care and early readmission: a metaanalysis of the evidence. Medical Care 35: 1044-1059, 1997 (Pubitemid 127458346)
50. Chinman M, Young AS, Rowe M, et al: An instrument to assess competencies of providers treating severe mental illness. Mental Health Services Research 5:97-108, 2003 (Pubitemid 36656411)
51. Marder SR, Essock SM, Miller AL, et al: Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 161:1334-1349, 2004 (Pubitemid 38989085)
52. Accreditation Organization Working Group: A Proposed Consensus Set of Indicators for Behavioral Health. Albuquerque, NM, American College of Mental Health Administration, 2001
53. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Clinical Guideline 1. London, National Institute for Clinical Excellence, 2002
54. Western Canada Waiting List Project Final Report: From Chaos to Order: Making Sense of Waiting Lists in Canada. Calgary, Alberta, Western Canada Waiting List Project, 2001
55. McEwan KL, Goldner EM: Keeping mental health reform on course: selecting indicators of mental health system performance. Canadian Journal of Community Mental Health 21:5-16, 2002 (Pubitemid 36395894)
56. Lehman AF, Kreyenbuhl J, Buchanan RW, et al: The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophrenia Bulletin 30:193-217, 2004 (Pubitemid 38828528)
57. Royal Australian and New Zealand College of Psychiatrists: Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. Australian and New Zealand Journal of Psychiatry 39:1-30, 2005
58. International Early Psychosis Association Writing Group: International clinical practice guidelines for early psychosis. British Journal of Psychiatry Supplement 48:120-124, 2005
59. Health Care in Canada. Ottawa, Ontario, Canadian Institute for Health Information, 2001
60. Hospital Report Research Collaborative: Hospital Report 2001 Preliminary Studies: Volume 1. Mental Health. Toronto, University of Toronto, 2001
61. National Committee for Quality Assurance: The State of Health Care Quality. Washington DC, National Committee for Quality Assurance, 2006
62. Druss B, Rosenheck R: Evaluation of the HEDIS measure of behavioral health care quality: Health Plan Employer Data and Information Set. Psychiatric Services 48:71-75, 1997 (Pubitemid 27024056)
63. Dickey B, Normand SL, Eisen S, et al: Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences. Medical Care 44:827-834, 2006 (Pubitemid 44306388)
64. Dixon LB, Dickerson F, Bellack AS, et al: The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin 36:48-70, 2010
65. Burns T: Hospitalisation as an outcome measure in schizophrenia. British Journal of Psychiatry Supplement 50:37-41, 2007
66. Addington DE, Beck C, Wang J, et al: Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. Psychiatric Services 61:483-488, 2010
67. Gleeson JF, Alvarez-Jimenez M, Cotton SM, et al: A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis. Schizophrenia Research 119:79-88, 2010